A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth

British Journal of Cancer

Volumn 105, Issue 7, 2011, Pages 1002-1011

  Colin, S ^a   Guilmain, W ^a,b   Creoff, E ^a,b   Schneider, C ^c   Steverlynck, C ^a   Bongaerts, M ^a   Legrand, E ^b   Vannier, J P ^b   Muraine, M ^b   Vasse, M ^b   Al Mahmood, S ^a  

^a Gene Signal Research Center   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c CNRS   (France)

Author keywords

angiogenesis; CD9P 1; GS 168AT2; lung cancer; tetraspanin

Indexed keywords

ANGIOGENESIS INHIBITOR; CD15 ANTIGEN; CD151 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; CD9 PARTNER 1 PROTEIN; CISPLATIN; GS 168AT2; IMMUNOGLOBULIN; MESSENGER RNA; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CAPILLARY; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANIMALS; AORTA; APOPTOSIS; BLOTTING, WESTERN; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UMBILICAL VEINS;

EID: 84860406817     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.303     Document Type: Article

References (35)

1. Al-Mahmood S (2000) Gene signal international SA, method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes, US patent no. 6716585
2. Al-Mahmood S, Colin S, Farhat N, Thorin E, Steverlynck C, Chemtob S (2009) Potent in vivo anti-angiogenic effects of GS-101, an antisense oligonucleotide preventing the expression of Insulin Receptor Substrate-1. J Pharmacol Exper Thera 329: 496-504
3. Al-Mahmood S, Colin S, Schneider C (2005) Gene signal international SA, genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof, EP patent no. 1566387
4. André M, Chambrion C, Charrin S, Soave S, Chaker J, Boucheix C, Rubinstein E, Le Naour F (2009) In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface. J Proteomics 73: 93-102
5. Balsari A, Tortoreto M, Besusso D, Petrangolini G, Sfondrini L, Maggi R, Ménard S, Pratesi G (2004) Combination of a CpG oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts. Eur J Cancer 40: 1275-1281 (Pubitemid 38526349)
6. Berditchevski F, Odintsova E, Sawada S, Gilbert E (2002) Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J Biol Chem 277: 36991-37000
7. Binétruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouët J, Derbin C, Perret G, Mazié JC (2000) Identification ofa peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J 19: 1525-1533 (Pubitemid 30182160)
8. Boucheix C, Rubinstein E (2001) Tetraspanins. Cell Mol Life Sci 58: 1189-1205 (Pubitemid 32844093)
9. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395 (Pubitemid 30208155)
10. Chambrion C, Le Naour F (2010) The tetraspanins CD9 and CD81 regulate CD9P1-induced effects on cell migration. PLoS One 5(6): e11219
11. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C, Rubinstein E (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276: 14329-14337
12. Charrin S, Manié S, Billard M, Ashman L, Gerlier D, Boucheix C, Rubinstein E (2003) Multiple levels of interactions within the tetraspanin web. Biochem Biophys Res Commun 304: 107-112 (Pubitemid 36434202)
13. Clarck K, Oelke A, Johnson ME, Eilert KD, Simpson PC, Todd SC (2004) CD81 associates with 14-3-3 in a redox-regulated palmitoylation-dependent manner. J Biol Chem 279: 19401-19406 (Pubitemid 38623373)
14. Cocquerel L, Voisset C, Dubuisson J (2006) Hepatitis C virus entry: potential receptors and their biological functions. J Gen Virol 87: 1075-1084
15. Deissler H, Kuhn EM, Lang GE, Deissler H (2007) Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Int J Mol Med 20: 643-652
16. Guilmain W, Colin S, Legrand E, Vannier JP, Steverlynck C, Bongarts M, Vasse M, Salman Al-Mahmood S (2011) CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits the in vivo tumor growth. Br J Cancer 104: 496-504
17. Hemler ME (2003) Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19: 397-422 (Pubitemid 37487354)
18. Klein-Soyer C, Azorsa DO, Cazenave JP, Lanza F (2000) CD9 participates in endothelial cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol 20: 360-369 (Pubitemid 30086091)
19. Kovalenko OV, Yang X, Kolesnikova TV, Hemler ME (2004) Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking. Biochem J 377: 407-417 (Pubitemid 38142196)
20. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR (1991) P53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51: 4090-4096
21. Levy S, Shoham T (2005) Protein-protein interactions in the tetraspanin web. Physiology (Bethesda) 20: 218-224 (Pubitemid 41215195)
22. Liang P, Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971
23. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD (1992) P53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171-180
24. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63 (Pubitemid 14203433)
25. Orlicky DJ, Nordeen SK (1996) Cloning, sequencing and proposed structure for a prostaglandin F2a receptor regulatory protein. Prostaglandins Leukot Essent Fatty Acids 55: 261-268 (Pubitemid 26384204)
26. Risau W (1997) Mechanisms of angiogenesis. Nature 386: 671-674 (Pubitemid 27193480)
27. Sato Y, Rifkin DB (1988) The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells. J Cell Biol 107: 1199-1205
28. Sheikh-Hamad D, Youker K, Luan D, Truong LD, Nielsen S, Entman ML (2000) Osmotically relevant membrane signaling complex: association between HB-EGF, beta 1-integrin, and CD9 in mTAL. Am J Physiol Cell Physiol 279: 136-146
29. Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, Renia L, Eling WH, Levy S, Boucheix C, Mazier D (2003) Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 9: 93-96 (Pubitemid 36098266)
30. Stipp CS, Kolesnikova TV, Hemler ME (2001) EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J Biol Chem 276: 40545-40554
31. Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, Kaipainen A, Hemler ME (2007) Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109: 1524-1532 (Pubitemid 46239585)
32. Tournaire R, Simon MP, Le-Noble F, Eichmann A, England P, Pouysségur J (2004) A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep 5: 262-267 (Pubitemid 38500105)
33. Yáñez-Mó M, Alfranca A, Cabañas C, Marazuela M, Tejedor R, Ursa MA, Ashman LK, de Landázuri MO, Sánchez-Madrid F (1998) Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol 141: 791-804 (Pubitemid 28217922)
34. Zhang F, Kotha J, Jennings LK, Zhang XA (2009) Tetraspanins and vascular functions. Cardiovasc Res 83: 7-15
35. Zhang XA, Kazarov AR, Yang X, Bontrager AL, Stipp CS, Hemler ME (2002) Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis. Mol Biol Cell 13: 1-11 (Pubitemid 34106054)